Kamini Govender developed a greener method for insulin biosynthesis, screened antiviral drugs during the COVID-19 pandemic, and overcame challenges with her genetic eye condition. She advocates for equity in science and sustainability in research.
She faced stigma due to her rare genetic eye condition, retinitis pigmentosa, which limited her peripheral vision but didn't deter her from achieving a PhD and continuing research work in biocatalysis.